Aurora Test for ART Donor Patients (AURORA-Donor) - Trial NCT06280677
Access comprehensive clinical trial information for NCT06280677 through Pure Global AI's free database. This phase not specified trial is sponsored by Fertiga, Belgium and is currently Recruiting. The study focuses on Infertility. Target enrollment is 160 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Fertiga, Belgium
Timeline & Enrollment
N/A
Feb 16, 2024
Sep 01, 2025
Primary Outcome
Basic clinical donor patient and stimulation characteristics: P4,Basic clinical donor patient and stimulation characteristics: E2,Basic clinical donor patient and stimulation characteristics: Gonadotropin type and dose,Clinical evaluation: number of Follicles,Clinical evaluation: number of cumulus-oocyte complex,Clinical evaluation: Meiosis II oocytes,Clinical evaluation: Abnormal fertilization,Clinical evaluation: Normal Fertilization,Clinical evaluation: Day 3 embryo evaluation,Clinical evaluation: Day 5/6 embryo evaluation,Clinical evaluation: Day5/6 good quality blastocyst rate,Clinical evaluation: Embryo utilization,Expression profile: blastocyst formation
Summary
This is a randomized observational study. The main aim is to determine potential oocyte
 competence predictive mRNA expression profiles in the cumulus cells isolated form individual
 oocytes. In 2 patient cohorts: 1)GnRH Antagonist & hr-FSH with GnRH Agonist trigger, 2)
 Progesterone & hr-FSH with GnRH Agonist trigger.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06280677
Non-Device Trial